Success Metrics

Clinical Success Rate
75.0%

Based on 3 completed trials

Completion Rate
75%(3/4)
Active Trials
1(11%)
Results Posted
33%(1 trials)
Terminated
1(11%)

Phase Distribution

Ph phase_4
2
22%
Ph not_applicable
7
78%

Phase Distribution

0

Early Stage

0

Mid Stage

2

Late Stage

Phase Distribution9 total trials
Phase 4Post-market surveillance
2(22.2%)
N/ANon-phased studies
7(77.8%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

60.0%

3 of 5 finished

Non-Completion Rate

40.0%

2 ended early

Currently Active

1

trials recruiting

Total Trials

9

all time

Status Distribution
Active(1)
Completed(3)
Terminated(2)
Other(3)

Detailed Status

unknown3
Completed3
Recruiting1
Terminated1
Withdrawn1

Development Timeline

Analytics

Development Status

Total Trials
9
Active
1
Success Rate
75.0%
Most Advanced
Phase 4

Trials by Phase

Phase 42 (22.2%)
N/A7 (77.8%)

Trials by Status

recruiting111%
terminated111%
unknown333%
withdrawn111%
completed333%

Recent Activity

Clinical Trials (9)

Drug Details

Intervention Type
PROCEDURE
Total Trials
9